Marshall Wace’s Clearside Biomedical CLSD Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-62,117
| Closed | -$80.8K | – | 2356 |
|
|
2024
Q2 | $80.8K | Sell |
62,117
-6,346
| -9% | -$8.25K | ﹤0.01% | 2190 |
|
|
2024
Q1 | $105K | Buy |
+68,463
| New | +$105K | ﹤0.01% | 2024 |
|
|
2022
Q4 | – | Sell |
-152,671
| Closed | -$173K | – | 2380 |
|
|
2022
Q3 | $173K | Sell |
152,671
-65,144
| -30% | -$73.8K | ﹤0.01% | 2368 |
|
|
2022
Q2 | $321K | Sell |
217,815
-194,216
| -47% | -$286K | ﹤0.01% | 2314 |
|
|
2022
Q1 | $943K | Buy |
+412,031
| New | +$943K | ﹤0.01% | 1880 |
|
|
2021
Q4 | – | Sell |
-53,474
| Closed | -$321K | – | 3208 |
|
|
2021
Q3 | $321K | Sell |
53,474
-176,967
| -77% | -$1.06M | ﹤0.01% | 2049 |
|
|
2021
Q2 | $1.12M | Sell |
230,441
-103,667
| -31% | -$505K | 0.01% | 1361 |
|
|
2021
Q1 | $825K | Buy |
+334,108
| New | +$825K | ﹤0.01% | 1477 |
|
|
2017
Q1 | – | Sell |
-449,820
| Closed | -$4.02M | – | 376 |
|
|
2016
Q4 | $4.02M | Buy |
449,820
+289,820
| +181% | +$2.59M | 0.03% | 518 |
|
|
2016
Q3 | $2.78M | Hold |
160,000
| – | – | 0.02% | 524 |
|
|
2016
Q2 | $1.12M | Buy |
+160,000
| New | +$1.12M | 0.01% | 686 |
|